Halozyme Therapeutics Inc $14.46
|Trade Time:||Dec 06 04:00 PM Eastern Daylight Time|
|Change:||0.07 (0.49 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get HALO Trend Analysis - it has outperformed the S&P 500 by 125%
|Date||Name||Title||Volume||Trade Price||Holding Change|
|10/15/2013||KIRK RANDAL J||Senior Executive Officer||10,000||$4.94||0.29%|
|9/16/2013||RAMSAY DAVID A||VP and Chief Financial Officer||130,000||$0.39||121.80%|
|9/16/2013||PATTON JOHN STUART||Director||-37,500||$9.17||-19.48%|
|9/13/2013||PATTON JOHN STUART||Director||-37,500||$9.10||-16.30%|
|9/13/2013||PATTON JOHN STUART||Director||100,000||$0.39||76.92%|
HALO Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!